A breakthrough drug recently approved to treat advanced pancreatic cancer may show promise against lung cancer as well, a new study suggests.

Results bolster hopes that the drug daraxonrasib could prove effective against a variety of tumours.

An oral drug widely expected to transform pancreatic cancer treatment has demonstrated encouraging clinical activity in metastatic non-small cell lung cancer. Daraxonrasib…